Key facts
- The FDA has launched a safety study of mifepristone.
- Mifepristone is an abortion pill.
- The study could lead to restrictions on its distribution and use.
- The study is expected to take about six months.
The U.S. Food and Drug Administration (FDA) has initiated a safety study concerning mifepristone, a medication commonly used for abortions. This move is seen as a potential precursor to future restrictions on how the drug is distributed and utilized. The study is anticipated to span approximately six months, with its findings likely to be released after the upcoming midterm elections. Such a development could pave the way for a future Trump administration to implement limitations on the pill's accessibility.